Re­ci­pharm to con­struct new In­di­an fill-fin­ish fa­cil­i­ty as part of ex­ist­ing re­la­tion­ship with Nichep­harm found­ing fam­i­ly'

In­dia is get­ting a man­u­fac­tur­ing boost that will add the ca­pac­i­ty to pro­duce an­oth­er 1 bil­lion in­jecta­bles.

Re­ci­pharm an­nounced the con­struc­tion of a new fill …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.